Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cetilistat (ATL-962) vs Orlistat in Obese Type 2 Diabetes
NCT00156897Phase 2Completed
- Sponsor
- Alizyme
- Start
- Dec 2004
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 2 trial of cetilistat in obesity, sponsored by Alizyme. Started Dec 2004; status: completed.
02
Drugs
cetilistat
03
Conditions
obesity
Beyond the preview
Go deeper on NCT00156897.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00156897.